771
Views
6
CrossRef citations to date
0
Altmetric
Review

Nanocrystals for controlled delivery: state of the art and approved drug products

, , &
Pages 1303-1316 | Received 13 May 2022, Accepted 03 Aug 2022, Published online: 08 Aug 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Qing Xia, Jiaqi Shen, Huining Ding, Siyi Liu, Fei Li, Fengqian Li & Nianping Feng. (2023) Intravenous nanocrystals: fabrication, solidification, in vivo fate, and applications for cancer therapy. Expert Opinion on Drug Delivery 0:0, pages 1-22.
Read now

Articles from other publishers (5)

Shan Huang, Dongdong Xu, Li Zhang, Liang Hao, Yujie Jia, Xianlong Zhang, Tao Cheng & Jian Chen. (2023) Therapeutic effects of curcumin liposomes and nanocrystals on inflammatory osteolysis: In vitro and in vivo comparative study. Pharmacological Research 192, pages 106778.
Crossref
Bwalya A. Witika, Yahya E. Choonara & Patrick H. Demana. (2023) A SWOT analysis of nano co-crystals in drug delivery: present outlook and future perspectives. RSC Advances 13:11, pages 7339-7351.
Crossref
Julia Sapienza Passos, Vanessa F.M.C. Dartora, Giovanna Cassone Salata, Isabella Draszesski Malagó & Luciana B. Lopes. (2023) Contributions of nanotechnology to the intraductal drug delivery for local treatment and prevention of breast cancer. International Journal of Pharmaceutics 635, pages 122681.
Crossref
Yuanchao Jia, Yuxin Jiang, Yonglong He, Wanting Zhang, Jiahui Zou, Kosheli Thapa Magar, Hamza Boucetta, Chao Teng & Wei He. (2023) Approved Nanomedicine against Diseases. Pharmaceutics 15:3, pages 774.
Crossref
Hafsa Shahid Faizi, Lalitkumar K. Vora, Muhammad Iqbal Nasiri, Yu Wu, Deepakkumar Mishra, Qonita Kurnia Anjani, Alejandro J. Paredes, Raghu Raj Singh Thakur, Muhammad Usman Minhas & Ryan F. Donnelly. (2022) Deferasirox Nanosuspension Loaded Dissolving Microneedles for Intradermal Delivery. Pharmaceutics 14:12, pages 2817.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.